Market Value2,183,559,000
Total Holdings65
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASMB / Assembly Biosciences, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
DICE / DICE Therapeutics Inc
GBT / Global Blood Therapeutics Inc.
HZNP / Horizon Therapeutics Plc
NVCR / NovoCure Limited
SDGR / Schrödinger, Inc.
LIFE / aTyr Pharma, Inc.
IMVT / Immunovant, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
GRTS / Gritstone bio, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
MDGL / Madrigal Pharmaceuticals, Inc.
MGTA / Magenta Therapeutics Inc
AGEN / Agenus Inc.
ANAB / AnaptysBio, Inc.
GHRS / GH Research PLC
NRIX / Nurix Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
NKTX / Nkarta, Inc.
/ Third Harmonic Bio, Inc.
TNYA / Tenaya Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
ISEE / IVERIC bio Inc Call
ISEE / IVERIC bio Inc
VERV / Verve Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
PTGX / Protagonist Therapeutics, Inc. Put
ALNY / Alnylam Pharmaceuticals, Inc. Call
BMRN / BioMarin Pharmaceutical Inc.
ARDX / Ardelyx, Inc.
JAZZ / Jazz Pharmaceuticals plc
RETA / Reata Pharmaceuticals Inc - Class A Put
ACAD / ACADIA Pharmaceuticals Inc.
KROS / Keros Therapeutics, Inc.
JNCE / Jounce Therapeutics Inc
NUVB / Nuvation Bio Inc.
ACET / Adicet Bio, Inc.
INZY / Inozyme Pharma, Inc.
BEAM / Beam Therapeutics Inc.
RLMD / Relmada Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc. Call
TCDA / Tricida Inc Call
AUPH / Aurinia Pharmaceuticals Inc.
ALBO / Albireo Pharma Inc
ESPR / Esperion Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
TCDA / Tricida Inc
PASG / Passage Bio, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
HOOK / HOOKIPA Pharma Inc.
FMTX / Forma Therapeutics Holdings Inc
TVTX / Travere Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
ETNB / 89bio, Inc.
ALLK / Allakos Inc.
DYN / Dyne Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
KURA / Kura Oncology, Inc.
HRTX / Heron Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
SWTX / SpringWorks Therapeutics, Inc.